Mila Lovrić

1.1k total citations
48 papers, 842 citations indexed

About

Mila Lovrić is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Psychiatry and Mental health. According to data from OpenAlex, Mila Lovrić has authored 48 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pediatrics, Perinatology and Child Health, 13 papers in Oncology and 11 papers in Psychiatry and Mental health. Recurrent topics in Mila Lovrić's work include Drug Transport and Resistance Mechanisms (11 papers), Pharmacological Effects and Toxicity Studies (11 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Mila Lovrić is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Pharmacological Effects and Toxicity Studies (11 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Mila Lovrić collaborates with scholars based in Croatia, Germany and United States. Mila Lovrić's co-authors include Nada Božina, Vlasta Bradamante, Alma Mihaljević Peleš, Martina Rojnić Kuzman, Marina Šagud, Ivan Adamec, Anamari Junaković, Mario Habek, Nikolina Jovanović and Vesna Medved and has published in prestigious journals such as American Journal of Physiology-Renal Physiology, Clinical Neurophysiology and Journal of the Neurological Sciences.

In The Last Decade

Mila Lovrić

45 papers receiving 814 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mila Lovrić Croatia 16 269 211 211 165 162 48 842
Junji Saruwatari Japan 22 244 0.9× 220 1.0× 131 0.6× 249 1.5× 259 1.6× 108 1.4k
Kentaro Oniki Japan 20 80 0.3× 163 0.8× 77 0.4× 141 0.9× 227 1.4× 87 1.1k
Pablo Zubiaur Spain 17 332 1.2× 164 0.8× 130 0.6× 171 1.0× 161 1.0× 73 877
Nada Božina Croatia 23 482 1.8× 355 1.7× 423 2.0× 386 2.3× 242 1.5× 86 1.5k
Chien-Hsiun Chen Taiwan 17 445 1.7× 107 0.5× 105 0.5× 59 0.4× 300 1.9× 41 1.4k
Suzanne Lemler United States 11 433 1.6× 72 0.3× 664 3.1× 69 0.4× 239 1.5× 11 1.6k
Gina Mejía‐Abril Spain 15 259 1.0× 128 0.6× 108 0.5× 105 0.6× 123 0.8× 49 647
Alberto Chiappe Switzerland 7 454 1.7× 179 0.8× 160 0.8× 29 0.2× 248 1.5× 8 960
M. Rebsamen Switzerland 11 305 1.1× 158 0.7× 113 0.5× 24 0.1× 191 1.2× 14 742
Bojan Lalovic United States 11 205 0.8× 239 1.1× 82 0.4× 29 0.2× 78 0.5× 23 992

Countries citing papers authored by Mila Lovrić

Since Specialization
Citations

This map shows the geographic impact of Mila Lovrić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mila Lovrić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mila Lovrić more than expected).

Fields of papers citing papers by Mila Lovrić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mila Lovrić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mila Lovrić. The network helps show where Mila Lovrić may publish in the future.

Co-authorship network of co-authors of Mila Lovrić

This figure shows the co-authorship network connecting the top 25 collaborators of Mila Lovrić. A scholar is included among the top collaborators of Mila Lovrić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mila Lovrić. Mila Lovrić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lovrić, Mila, et al.. (2024). Validation of a simple bioanalytical method for the determination of melatonin concentration in human serum using high-performance liquid chromatography with a fluorescent detector. Journal of Liquid Chromatography & Related Technologies. 47(11-15). 201–207. 1 indexed citations
2.
Kopčinović, Lara Milevoj, et al.. (2022). Verification policies in Croatian medical biochemistry laboratories: a survey of the practice. University of Zagreb University Computing Centre (SRCE). 4 indexed citations
6.
Lovrić, Mila, et al.. (2021). 194 Late-presenting acetaminophen self-poisoning. Abstracts. A82.2–A83.
7.
Habek, Mario, et al.. (2020). The association between the adrenergic hyperactivity and blood pressure values in people with multiple sclerosis. Neurological Sciences. 41(11). 3157–3164. 2 indexed citations
8.
Breljak, Davorka, Jovica Lončar, Mila Lovrić, et al.. (2018). Sex-independent expression of chloride/formate exchanger Cfex (Slc26a6) in rat pancreas, small intestine, and liver, and male-dominant expression in kidneys. Archives of Industrial Hygiene and Toxicology. 69(4). 286–303. 6 indexed citations
9.
Ganoci, Lana, et al.. (2017). Genetic polymorphisms of cytochrome P450 enzymes: CYP2C9 , CYP2C19 , CYP2D6 , CYP3A4 , and CYP3A5 in the Croatian population. Drug Metabolism and Personalized Therapy. 32(1). 11–21. 26 indexed citations
10.
Šagud, Marina, et al.. (2016). Olanzapine Long-Acting Injections After Neuroleptic Malignant Syndrome. Journal of Clinical Psychopharmacology. 36(6). 733–735. 1 indexed citations
11.
Ganoci, Lana, et al.. (2016). The Role Of Cyp2d6, Cyp3a4/5, And Abcb1 Polymorphisms In Patients Using Long-Acting Injectable Risperidone. Clinical Therapeutics. 38(10). e10–e11. 5 indexed citations
12.
Habek, Mario, Luka Crnošija, Mila Lovrić, et al.. (2016). Sympathetic cardiovascular and sudomotor functions are frequently affected in early multiple sclerosis. Clinical Autonomic Research. 26(6). 385–393. 54 indexed citations
13.
Lovrić, Mila, et al.. (2012). Association Between Lamotrigine Concentrations and ABCB1 Polymorphisms in Patients With Epilepsy. Therapeutic Drug Monitoring. 34(5). 518–525. 40 indexed citations
14.
Jovanović, Nikolina, Nada Božina, Mila Lovrić, et al.. (2010). The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone. European Journal of Clinical Pharmacology. 66(11). 1109–1117. 78 indexed citations
15.
Božina, Nada, Nikolina Jovanović, Mila Lovrić, & Vesna Medved. (2008). Clinical Significance of a CYP2D6 Poor Metabolizer -A Patient With Schizophrenia on Risperidone Treatment. Therapeutic Drug Monitoring. 30(6). 748–751. 8 indexed citations
16.
Lovrić, Mila, et al.. (2007). Whole blood S-adenosylhomoysteine - a reliable biomarker of S-adenosylhomocysteine hydrolase deficiency. Journal of Inherited Metabolic Disease. 30. 1 indexed citations
17.
Ćuk, Mario, Mila Lovrić, Ksenija Fumić, et al.. (2007). The fourth S-adenosylhomocysteine hydrolase deficient patient : Further evidence of congenital miopathy. Clinical Chemistry and Laboratory Medicine (CCLM). 43. 8 indexed citations
18.
Božina, Nada, et al.. (2005). Genetic polymorphismes of Cytochromes P450: CYP2C9, CYP2C19 and MDR1 genes and their effect on phenytoin disposition. Periodicum Biologorum. 107(2). 183–187. 1 indexed citations
19.
Božina, Nada, et al.. (2003). Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.. PubMed. 44(4). 425–8. 86 indexed citations
20.
Lovrić, Mila, et al.. (2003). Monitoring antioxidative ability in patients with traumatic shock. Clinical Chemistry and Laboratory Medicine (CCLM). 41.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026